SCHEMBL1324554

SCHEMBL1324554

PCCCCCC(C1CCCC1)C1CCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.39
CYP2D6 P10635 2/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
TSHR P16473 1/20 0.31
KMT2A Q03164 1/20 0.31
MLNR O43193 1/20 0.31
ABCB11 O95342 1/20 0.31
EGFR P00533 1/20 0.31
FYN P06241 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
HTR1A P08908 1/20 0.31
CHRM5 P08912 1/20 0.31
ADRA2A P08913 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
CHRM1 P11229 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1323180 1.00 EPHX1 (0.39) EPHX1CYP2D6MEN1ALDH1A1LMNA
SCHEMBL1323141 0.98 EPHX1 (0.43) EPHX1CYP2D6MEN1ALDH1A1LMNA
SCHEMBL1337268 0.98 EPHX1 (0.43) EPHX1CYP2D6MEN1ALDH1A1LMNA
SCHEMBL17529700 0.98 EPHX1 (0.43) EPHX1CYP2D6MEN1ALDH1A1LMNA
SCHEMBL11730380 0.98 EPHX1 (0.43) EPHX1CYP2D6MEN1ALDH1A1LMNA
SCHEMBL1324615 0.98 EPHX1 (0.41) EPHX1CYP2D6MEN1ALDH1A1LMNA
SCHEMBL17529723 0.95 EPHX1 (0.44) EPHX1CYP2D6MEN1ALDH1A1LMNA
SCHEMBL1324545 0.91 EPHX1 (0.42) EPHX1CYP2D6MEN1ALDH1A1LMNA
SCHEMBL1324498 0.88 EPHX1 (0.46) EPHX1CYP2D6MEN1ALDH1A1LMNA
SCHEMBL1323171 0.80 EPHX1 (0.46) EPHX1CYP2D6MEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12492281-B2 Polyisocyanurate materials as electrical potting compounds COVESTRO DEUTSCHLAND AG (DE) 2025-12-09 US disclosed
CN-113631545-B Polyisocyanurate materials as electrical potting compounds 科思创德国股份有限公司 2025-01-07 CN disclosed
CN-112204065-B Process for preparing polyisocyanate polymers and polyisocyanurate plastics 科思创知识产权两合公司 2023-03-28 CN disclosed
CN-109642015-B Method for producing polyisocyanurate plastics by means of phosphine catalysis 科思创德国股份有限公司 2022-09-23 CN disclosed
EP-3794049-B1 METHOD FOR PRODUCING A POLYISOCYANATE POLYMER AND A POLYISOCYANURATE PLASTIC COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-06-08 EP disclosed
US-11319402-B2 Method for producing a polyisocyanate polymer and a polyisocyanurate plastic COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2022-05-03 US disclosed
US-20220127407-A1 POLYISOCYANURATE MATERIALS AS ELECTRICAL POTTING COMPOUNDS COVESTRO DEUTSCHLAND AG (DE) 2022-04-28 US disclosed
US-11279790-B2 Process for producing polyisocyanurate plastics by means of phosphine catalysis COVESTRO DEUTSCHLAND AG (DE) 2022-03-22 US disclosed
EP-3507321-B1 PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-03-02 EP disclosed
EP-3931185-A1 POLYISOCYANURATE MATERIALS AS ELECTRICAL POTTING COMPOUNDS Covestro Intellectual Property GmbH & Co. KG (DE) 2022-01-05 EP disclosed
EP-3794049-A1 METHOD FOR PRODUCING A POLYISOCYANATE POLYMER AND A POLYISOCYANURATE PLASTIC Covestro Intellectual Property GmbH & Co. KG (DE) 2021-03-24 EP disclosed
CN-112204065-A Process for preparing polyisocyanate polymers and polyisocyanurate plastics 科思创知识产权两合公司 2021-01-08 CN disclosed
US-10464948-B2 Polycyclic diiminooxadiazinones COVESTRO DEUTSCHLAND AG (DE) 2019-11-05 US disclosed
EP-3507321-A1 PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS Covestro Deutschland AG (DE) 2019-07-10 EP disclosed
US-20190202963-A1 PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS COVESTRO DEUTSCHLAND AG (DE) 2019-07-04 US disclosed
US-20180346482-A1 POLYCYCLIC DIIMINOOXADIAZINONES COVESTRO DEUTSCHLAND AG (DE) 2018-12-06 US disclosed
WO-2018041800-A1 PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS COVESTRO DEUTSCHLAND AG (DE) 2018-03-08 WO disclosed
US-8058382-B2 Uretdione formation in solution BAYER MATERIALSCIENCE AG (DE) 2011-11-15 US disclosed
US-20110275802-A1 METHOD FOR MODIFYING DIISOCYANATES BAYER MATERIALSCIENCE AG (DE) 2011-11-10 US disclosed
US-20060173152-A1 Uretdione formation in solution BAYER MATERIALSCIENCE AG 2006-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10464948-B2 Polycyclic diiminooxadiazinones CYP11B2, CBR1, IDH2 EPHX1 2041/4885CYP2D6 35/4885MEN1 2586/4885
US-20180346482-A1 POLYCYCLIC DIIMINOOXADIAZINONES CYP11B2, CBR1, IDH2 EPHX1 2041/4885CYP2D6 35/4885MEN1 2586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.